Stocks · US
GILD
XNAS
Gilead Sciences Inc
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B15.16x
P/S5.89x
EPS$-2.61
ROE-27.39%
ROA-6.56%
Dividend yield2.27%
EV/EBITDA62.70x
Debt/Equity2.22
Free cash flow$12.9B
Returns and 52-week range
1W-4.66%
1M-4.48%
3M+6.19%
6M+3.91%
1Y+27.99%
YTD+18.61%
52W high$157.29
52W low$114.02
From 52W high-8.30%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 암젠 | $217.9B | 24.92 | 18.64 | -7.92% |
| 애보트 래브러토리스 | $173.2B | 31.93 | 3.39 | -9.39% |
| 아스트라제네카 | $242.8B | 109.30 | 17.94 | -2.51% |
| 화이자 | $156.2B | 36.06 | 1.83 | -3.34% |
| 써모 피셔 사이언티픽 | $250.2B | 35.92 | 4.75 | +6.97% |
| 다나허 | $155.5B | 38.84 | 2.96 | +3.83% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.